It has been shown that CCL2 expression is repressed in MYCN-amplified neuroblastoma cells (21), and our analysis using two different public transcriptomic datasets confirm that CCL2 transcription was lower in MYCN-amplified neuroblastoma (which may arise from tumor or immune cells). The gene discussed is MYCN; the disease is neoplasm.